drugset / Trial / NCT03786887

The 90% Effective Dose of Nalbuphine in Mechanical Ventilated Patients in the ICU

NCT03786887

Phase 4 Unknown 60 enrolled Hua-Qing Shu
SequentialOpen-labelTreatment

Summary

The aim of this study is to determine the effective nalbuphine dose in 90% of intubated patients in the ICU, including the continuous infusion dose and a bolus dose during moving to the lateral decubitus position. Pain will assessed using a Behavioural Pain Scale (BPS) requiring a score of 3-4.

Timeline

Start
2018-10-24
Primary completion
2019-10
Completion
2019-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalbuphine Small molecule 0 mg/kg
Subject Nalbuphine Small molecule 100 ug/kg

Indications

No indication recorded.